HK1067299A1 - Pharmaceutical compositions containing terbinafineand use thereof - Google Patents

Pharmaceutical compositions containing terbinafineand use thereof

Info

Publication number
HK1067299A1
HK1067299A1 HK04108132A HK04108132A HK1067299A1 HK 1067299 A1 HK1067299 A1 HK 1067299A1 HK 04108132 A HK04108132 A HK 04108132A HK 04108132 A HK04108132 A HK 04108132A HK 1067299 A1 HK1067299 A1 HK 1067299A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
terbinafineand
compositions containing
minitablets
terbinafine
Prior art date
Application number
HK04108132A
Other languages
English (en)
Inventor
Alles Rainer
Becker Dieter
Bonny Jean-Daniel
Hirsch Stefan
Kalb Oskar
Koille Ernst Ulrich
Mayer Friedrich Karl
Stuetz Anton
Williams Anthony
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27256227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1067299(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0117760A external-priority patent/GB0117760D0/en
Priority claimed from GB0128993A external-priority patent/GB0128993D0/en
Priority claimed from GB0212209A external-priority patent/GB0212209D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1067299A1 publication Critical patent/HK1067299A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
HK04108132A 2001-07-20 2004-10-18 Pharmaceutical compositions containing terbinafineand use thereof HK1067299A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0117760A GB0117760D0 (en) 2001-07-20 2001-07-20 Organic compounds
GB0128993A GB0128993D0 (en) 2001-12-04 2001-12-04 Organic compounds
GB0212209A GB0212209D0 (en) 2002-05-27 2002-05-27 Organic compounds
PCT/EP2002/008095 WO2003022267A1 (en) 2001-07-20 2002-07-19 Pharmaceutical compositions containing terbinafin and use thereof

Publications (1)

Publication Number Publication Date
HK1067299A1 true HK1067299A1 (en) 2005-04-08

Family

ID=27256227

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108132A HK1067299A1 (en) 2001-07-20 2004-10-18 Pharmaceutical compositions containing terbinafineand use thereof

Country Status (28)

Country Link
US (2) US20040198838A1 (ja)
EP (1) EP1411921B2 (ja)
JP (3) JP2005503399A (ja)
KR (2) KR100651110B1 (ja)
CN (1) CN100358518C (ja)
AR (1) AR034813A1 (ja)
AT (1) ATE381329T1 (ja)
AU (1) AU2002321249B2 (ja)
BR (1) BR0211198A (ja)
CA (1) CA2453263C (ja)
CY (1) CY1107861T1 (ja)
DE (1) DE60224194T3 (ja)
DK (1) DK1411921T4 (ja)
ES (1) ES2295381T5 (ja)
HK (1) HK1067299A1 (ja)
HU (1) HUP0401200A3 (ja)
IL (2) IL159591A0 (ja)
MX (1) MXPA04000627A (ja)
MY (1) MY136136A (ja)
NO (1) NO332268B1 (ja)
NZ (1) NZ530648A (ja)
PE (1) PE20030287A1 (ja)
PL (1) PL365416A1 (ja)
PT (1) PT1411921E (ja)
RU (1) RU2298402C2 (ja)
SI (1) SI1411921T2 (ja)
TW (1) TWI302460B (ja)
WO (1) WO2003022267A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2004004700A1 (en) * 2002-07-02 2004-01-15 Novartis Ag Methods for the treatment of sinusitis
JP2005060310A (ja) * 2003-08-13 2005-03-10 Towa Yakuhin Kk 不快な味をマスキングする経口投与用製剤
JP2005187339A (ja) * 2003-12-24 2005-07-14 Iwaki Seiyaku Co Ltd 耐光性塩酸テルビナフィンフィルムコート錠
JP4999297B2 (ja) * 2005-08-10 2012-08-15 高田製薬株式会社 高含量塩酸テルビナフィン小型錠剤
US8815285B2 (en) * 2006-03-28 2014-08-26 Wockhardt Ltd. Extended release dosage forms of metoprolol
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
PL2010158T3 (pl) * 2006-04-26 2016-09-30 Formulacje o kontrolowanym uwalnianiu zawierające niepowlekaną odrębną jednostkę(-i) i macierz o przedłużonym uwalnianiu
AU2007255392B2 (en) * 2006-06-07 2011-09-22 Novartis Ag Process for making multiparticulates using a roller compactor
RU2535090C2 (ru) * 2009-01-28 2014-12-10 Новартис Аг Галеновы препараты органических соединений
WO2010086727A1 (en) * 2009-01-30 2010-08-05 Galderma Pharma Sa Stable compositions for nail onychomycosis treatment
CN102198111A (zh) * 2011-06-17 2011-09-28 哈尔滨乐泰药业有限公司 一种抗真菌药物片剂的制备方法
WO2013043143A1 (ru) * 2011-09-21 2013-03-28 Slyusar Viktor Timopheevich Способ снижения лишнего веса
WO2013134348A1 (en) * 2012-03-07 2013-09-12 Santarus, Inc. Controlled-release solid dosage forms of mesalamine
KR20190008840A (ko) 2016-03-15 2019-01-25 에이서 테라퓨틱스 인크. 소듐 페닐부티레이트를 포함하는 맛우수한 조성물 및 그의 용도
US11504687B2 (en) 2016-10-11 2022-11-22 Khalifa University of Science and Technology Coated chloride salt particles and methods of making and using the same
CN109833301A (zh) * 2017-11-29 2019-06-04 天津市保灵动物保健品有限公司 一种犬猫用盐酸特比萘芬风味片及其制备工艺
CN109925296B (zh) * 2017-12-19 2021-09-07 四川济生堂药业有限公司 一种中药微丸的包衣方法
CN112156078A (zh) * 2020-11-11 2021-01-01 乐泰药业有限公司 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) † 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5332727A (en) * 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
AU1313695A (en) * 1993-12-14 1995-07-03 Sandoz Ltd. Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
US5814230A (en) * 1996-08-30 1998-09-29 Willis; H. Craig Apparatus and method for separation of solids from liquid
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
AU715867B2 (en) * 1997-01-06 2000-02-10 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
US6342250B1 (en) * 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
FR2771291B1 (fr) † 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
DE19842753A1 (de) † 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
EP1133282A4 (en) * 1998-11-25 2006-03-29 Cima Labs Inc TASTE-MAKING DELIVERY SYSTEM WITH FAST RELEASE
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
DK1146862T3 (da) † 1999-01-29 2003-07-21 Disphar Int Bv Farmaceutiske sammensætninger
US6248363B1 (en) † 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
CN1116033C (zh) * 1999-07-08 2003-07-30 齐鲁制药厂 一种治疗阴道炎的泡腾片剂及其制法
AU765526B2 (en) * 1999-08-17 2003-09-18 Novartis Consumer Health S.A. Rapidly dissolving dosage form and process for making same
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
AU2001239838A1 (en) † 2000-02-24 2001-09-03 Advancis Pharmaceutical Corporation Therapeutic product, use and formulation thereof
DE10017996A1 (de) * 2000-04-11 2001-10-18 Pierre Foss Lamisil-Intervall-System
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2004069157A2 (en) * 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies

Also Published As

Publication number Publication date
KR100651110B1 (ko) 2006-12-21
CN1527706A (zh) 2004-09-08
WO2003022267A1 (en) 2003-03-20
KR20040028935A (ko) 2004-04-03
DK1411921T3 (da) 2008-04-21
ES2295381T5 (es) 2011-01-31
EP1411921B2 (en) 2010-08-18
US20080286356A1 (en) 2008-11-20
JP2012136523A (ja) 2012-07-19
AR034813A1 (es) 2004-03-17
HUP0401200A3 (en) 2008-03-28
ATE381329T1 (de) 2008-01-15
PE20030287A1 (es) 2003-05-06
DE60224194D1 (de) 2008-01-31
CA2453263C (en) 2010-12-07
TWI302460B (en) 2008-11-01
MY136136A (en) 2008-08-29
AU2002321249B2 (en) 2005-10-27
DE60224194T3 (de) 2011-03-17
NZ530648A (en) 2007-04-27
PT1411921E (pt) 2008-03-12
SI1411921T2 (sl) 2010-12-31
RU2298402C2 (ru) 2007-05-10
MXPA04000627A (es) 2004-04-20
EP1411921A1 (en) 2004-04-28
CA2453263A1 (en) 2003-03-20
KR100699958B1 (ko) 2007-03-28
PL365416A1 (en) 2005-01-10
HUP0401200A2 (hu) 2004-10-28
NO20040254L (no) 2004-03-22
IL159591A (en) 2012-06-28
US20040198838A1 (en) 2004-10-07
EP1411921B1 (en) 2007-12-19
BR0211198A (pt) 2004-08-10
SI1411921T1 (sl) 2008-06-30
NO332268B1 (no) 2012-08-13
DK1411921T4 (da) 2010-11-08
RU2004105263A (ru) 2005-04-20
CY1107861T1 (el) 2013-06-19
KR20060076331A (ko) 2006-07-04
ES2295381T3 (es) 2008-04-16
DE60224194T2 (de) 2008-12-24
JP2005503399A (ja) 2005-02-03
CN100358518C (zh) 2008-01-02
JP2008280351A (ja) 2008-11-20
IL159591A0 (en) 2004-06-01

Similar Documents

Publication Publication Date Title
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
TW200630123A (en) Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
UA63993C2 (uk) Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул
HU9700589D0 (en) Extended release formulation
CA2494234A1 (en) Methods and dosage forms for controlled delivery of paliperidone
EP2269613A3 (en) Solid orald dosage form comprising a combination of metformin and glibenclamide
HK1074581A1 (en) Pharmaceutical tablet
AU2431702A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
HK1083200A1 (en) Pharmaceutical preparations for oral administration, containing ion- exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
MY127350A (en) Flash-melt oral dose formulations
AU2084801A (en) Antiviral medication
NZ504460A (en) Sustained release formulations containing venlafaxine
WO2002024203A3 (en) Controlled release formulations for oral administration
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
MX2009006699A (es) Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos.
IL162385A (en) Benzothiazole - and benzoxazole - 4,7 - dione derivatives, uses thereof for the preparation of a medicament, medicaments containing them and pharmaceutical compositions containing them
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
MY145885A (en) Controlled release formulations for oral administration
ECSP024290A (es) Composiciones farmacéuticas y uso de las mismas
MY133368A (en) Process for preparing pharmaceutical compositions for use with soft gelatin formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140719